新型心血管磁共振通过时间在心室功能障碍患者中超越肺循环的预后价值
回顾性研究纳入139例因心室功能障碍行心脏磁共振评估的患者及50例对照,从中提取首过灌注图像上不同循环阶段(右心、左心、主动脉及外周器官)的通过时间。中位随访15个月,同时存在PTT>10 s和STT>5 s与更高事件概率相关(42.3%),联合PTT与STT改变独立预测复合终点(HR 8.685,95%CI 2.415-31.236,p=0.001),RPT延长独立与肾功能恶化相关。
要点
- 同时测PTT>10 s与STT>5 s者事件概率42.3%,孤立异常者仅6.3%与6.7%。
- 联合PTT与STT异常独立预测死亡、心衰入院或室性心律失常复合终点(HR 8.685)。
- RPT延长独立与肾功能恶化相关(OR 1.129,95%CI 1.015-1.256)。
核心结论
- 超越肺循环的通过时间评估可为心室功能障碍提供预后信息;同时评估PTT与STT较孤立PTT评估提高特异性,预测复合不良事件,RPT独立与肾功能受损相关。
研究设计与样本
- 回顾性研究,纳入139例因心室功能障碍行心脏磁共振评估的患者和50例对照,通过首过灌注图像测量不同循环阶段的通过时间,中位随访15个月。
关键影像表现/征象
- 患者通过时间较对照显著延长,住院患者较门诊患者更长。
- 达到主要终点的29例患者PTT与STT均显著延长(PTT:9.75 s vs 13.4 s,p < 0.01;STT:4.77 s vs 7.00 s,p < 0.01)。
- 同时存在PTT>10 s和STT>5 s者事件概率42.3%,孤立PTT异常者6.3%,孤立STT异常者6.7%。
诊断标准与关键数值
- PTT阈值>10 s且STT阈值>5 s同时延长时事件概率42.3%,孤立PTT异常为6.3%,孤立STT异常为6.7%。
- 联合PTT与STT改变预测复合终点:HR 8.685(95%CI 2.415-31.236),p = 0.001。
- RPT延长与肾功能恶化:OR 1.129(95%CI 1.015-1.256),p = 0.024。
临床应用与阅片要点
- 通过时间可从常规心脏磁共振灌注图像上测量,无需额外序列。
- 同时评估PTT与STT较单独PTT提高特异性,有助于识别随访期间发生事件的心室功能障碍患者。
- RPT延长提示肾功能恶化风险,可结合临床关注肾功能变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the prognostic value of transit time (TT) assessment in the systemic circulation and organ perfusion in patients with ventricular dysfunction (VD). The primary endpoint was defined as death, heart failure admission, or ventricular arrhythmias, and the secondary endpoint was worsening renal function.
METHODS: A retrospective study on 139 patients who underwent cardiac magnetic resonance for VD evaluation and 50 controls. TT was measured as peak-to-peak time in signal intensity over time curves obtained at different stages of circulation (right cavities, left cavities, aorta, and peripheral organs) from first-pass perfusion images. Outcomes were monitored over a median follow-up of 15 months.
RESULTS: A total of 139 patients were included (84% male, age 63 [57-70] years). Patients exhibited significantly prolonged TT compared to controls, with in-patients showing longer times than outpatients. Among the 29 patients reaching the primary endpoint, both PTT and STT were significantly prolonged (PTT: 9.75 s vs 13.4 s, p < 0.01; STT: 4.77 s vs 7.00 s, p < 0.01). Concurrent prolongation of PTT (> 10 s) and STT (> 5 s) was associated with a higher event probability (42.3%), compared to isolated abnormalities (6.3% for PTT, 6.7% for STT). Multivariate analysis revealed that combined PTT and STT alteration independently predicted the combined endpoint (HR IC 95%: 8.685 (2.415-31.236), p = 0.001). Prolonged RPT was independently associated with renal function deterioration (OR IC 95%: 1.129 (1.015-1.256), p = 0.024).
CONCLUSIONS: Evaluation of TT beyond pulmonary circulation provides prognostic insights into VD. Simultaneous assessment of PTT and STT enhances specificity compared to isolated PTT evaluation, predicting combined adverse events. RPT is independently associated with renal impairment.
CLINICAL RELEVANCE STATEMENT: For the first time, it is described that transit time can be evaluated in systemic circulation and in peripheral organs and that this assessment can be easily made from conventional CMR perfusion images and holds significant prognostic value.
KEY POINTS: Pulmonary transit time is a valuable hemodynamic parameter; systemic transit time may also be valuable. Transit time can be measured in the systemic circulation, and is longer in patients with ventricular dysfunction. Systemic transit time assessed by magnetic resonance imaging identifies patients with ventricular dysfunction who will experience events during follow-up.
引用
- Sevilla T, Baladrón C, de Miguel-Álava M, et al. Prognostic value of novel cardiovascular magnetic resonance transit times beyond the pulmonary circulation in patients with ventricular dysfunction. Eur Radiol. 2024. PMID: 39214894. doi:10.1007/s00330-024-11045-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。